Worth Financial Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Buy
+1,524
New +$1.56M 0.76% 32
2026
Q1
Sell
-1,369
Closed -$1.47M 125
2025
Q4
$1.47M Buy
1,369
+27
+2% +$25.8K 0.71% 31
2025
Q3
$1.02M Buy
1,342
+54
+4% +$40.2K 0.57% 37
2025
Q2
$1M Buy
1,288
+67
+5% +$52.1K 0.62% 37
2025
Q1
$1.01M Buy
1,221
+918
+303% +$764K 0.64% 37
2024
Q4
$234K Sell
303
-407
-57% -$337K 0.14% 140
2024
Q3
$629K Buy
+710
New +$638K 0.37% 67

Other funds holding LLY

Worth Financial Advisory Group's LLY Position: Q2 2026 in Review

Worth Financial Advisory Group opened a new position in Eli Lilly (LLY) in Q2 2026: 1,524 shares worth $1.83M. The stake represents 0.76% of the portfolio and ranks #32 among its holdings. This is a return to the name: Worth Financial Advisory Group previously reported a position in LLY as recently as Q4 2025.

Worth Financial Advisory Group first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Worth Financial Advisory Group held 1,524 shares of Eli Lilly worth $1.83M as of Q2 2026.
  • Eli Lilly was a new Worth Financial Advisory Group position in Q2 2026.
  • Eli Lilly made up 0.76% of Worth Financial Advisory Group's portfolio in Q2 2026, its #32 holding.
  • Worth Financial Advisory Group first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Worth Financial Advisory Group's 13F filing for Q2 2026, filed 31 Jul 2026.